|
|
| Line 69: |
Line 69: |
| | <!-- add device list below --> | | <!-- add device list below --> |
| | | | |
| - | <h3 style="font-weight:bold;">Parts/Devices available upon request</h3> | + | <p>During the summer we built more than 60 devices under the BioBrick standard <a href="https://2009.igem.org/Judging/Variance/UCSF" target="_blank">RFC28</a> (see more info <a href="http://dspace.mit.edu/bitstream/handle/1721.1/46721/BBFRFC28.pdf" target="_blank">here</a>), which was developed by the UCSF team in 2009 and was approved by the Registry of Parts. However, this year the Registry does not accept RFC28. Due to time constrains, we could not move all of these parts into pSB1C3 and submit them as we had planned.</p><br> |
| | | | |
| - | <p>During the summer we built the following devices under the BioBrick standard <a href="https://2009.igem.org/Judging/Variance/UCSF" target="_blank">RFC28</a> (see more info <a href="http://dspace.mit.edu/bitstream/handle/1721.1/46721/BBFRFC28.pdf" target="_blank">here</a>), which was developed by the UCSF team in 2009 and was approved by the Registry of Parts. However, this year the Registry does not accept RFC28. Due to time constrains, we could not move all of these parts into pSB1C3 and submit them as we had planned.</p><br> | + | <!-- |
| | | | |
| | <table id="customers"> | | <table id="customers"> |
| Line 81: |
Line 81: |
| | <tr> | | <tr> |
| | <td>Carmen</td> | | <td>Carmen</td> |
| - | <td>Old antiMesoCAR-LFA1-Dap10</td> | + | <td>device</td> |
| - | <td>Stronger Signaling</td> | + | <td>purpose</td> |
| | </tr> | | </tr> |
| | | | |
| | <tr class="alt"> | | <tr class="alt"> |
| | <td>John</td> | | <td>John</td> |
| - | <td>antiCD19CAR-DAP10-STOP</td> | + | <td>device</td> |
| - | <td>Positive Control</td> | + | <td>purpose</td> |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <td>Hannah</td>
| + | |
| - | <td>antiCD19CAR-mDAP10y85F-STOP</td>
| + | |
| - | <td>Stronger Signaling</td>
| + | |
| - | </tr>
| + | |
| - | | + | |
| - | <tr class="alt">
| + | |
| - | <td>Lianna</td>
| + | |
| - | <td>antiCD19CAR-mDAP10N87Q-STOP</td>
| + | |
| - | <td>Negative Control</td>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <td>Sam</td>
| + | |
| - | <td>antiMESOCAR-mDAP10N87Q-STOP</td>
| + | |
| - | <td>Logic Gate Signaling</td>
| + | |
| - | </tr>
| + | |
| - | | + | |
| - | <tr class="alt">
| + | |
| - | <td>Crystal</td>
| + | |
| - | <td>antiMESOCAR-DAP10-CD3Z</td>
| + | |
| - | <td>Stronger Signaling</td>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <td>Crystal</td>
| + | |
| - | <td>antiMESOCAR- LFA1-CD3z</td>
| + | |
| - | <td>Stronger Signaling</td>
| + | |
| - | </tr>
| + | |
| - | | + | |
| - | <tr class="alt">
| + | |
| - | <td>Crystal</td>
| + | |
| - | <td>antiMESOCAR-DAP10-DAP10</td>
| + | |
| - | <td>Stronger Signaling</td>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <td>Sam</td>
| + | |
| - | <td>antiCD19CAR-DAP10-CD3z</td>
| + | |
| - | <td>Stronger Signaling</td>
| + | |
| - | </tr>
| + | |
| - | | + | |
| - | <tr class="alt">
| + | |
| - | <td>Sam</td>
| + | |
| - | <td>antiCD19CAR-DAP10-Dap10</td>
| + | |
| - | <td>Stronger Signaling</td>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <td>Sam</td>
| + | |
| - | <td>antiCD19CAR-CD3z-CD3z</td>
| + | |
| - | <td>Stronger Signaling</td>
| + | |
| - | </tr>
| + | |
| - | | + | |
| - | <tr class="alt">
| + | |
| - | <td>Carmen</td>
| + | |
| - | <td>antiMESOCAR-CD3Z-STOP</td>
| + | |
| - | <td>Positive Control</td>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <td>Carmen</td>
| + | |
| - | <td>antiCD19-CD3z-STOP</td>
| + | |
| - | <td>Stronger Signaling</td>
| + | |
| - | </tr>
| + | |
| - | | + | |
| - | <tr class="alt">
| + | |
| - | <td>Carmen</td>
| + | |
| - | <td>antiMESOCAR-KIR3DL2-STOP</td>
| + | |
| - | <td>Inhibition</td>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <td>Carmen</td>
| + | |
| - | <td>antiCD19CAR-KIR3DL2-STOP</td>
| + | |
| - | <td>Inhibition</td>
| + | |
| - | </tr>
| + | |
| - | | + | |
| - | <tr class="alt">
| + | |
| - | <td>Crystal</td>
| + | |
| - | <td>antiMESOCAR-LFA1-DAP10</td>
| + | |
| - | <td>Stronger Signaling</td>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <td>Crystal</td>
| + | |
| - | <td>antiMESOCAR-mDAP10 M88Q-STOP</td>
| + | |
| - | <td>Logic Gate Signaling</td>
| + | |
| - | </tr>
| + | |
| - | | + | |
| - | <tr class="alt">
| + | |
| - | <td>Crystal</td>
| + | |
| - | <td>antiCD19CAR-mDAP10 M88Q-STOP</td>
| + | |
| - | <td>Logic Gate Signaling</td>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <td>Lianna</td>
| + | |
| - | <td>antiMESOCAR-OX40-Dap10</td>
| + | |
| - | <td>Stronger Signaling</td>
| + | |
| - | </tr>
| + | |
| - | | + | |
| - | <tr class="alt">
| + | |
| - | <td>Lianna</td>
| + | |
| - | <td>antiMESOCAR-OX40-CD3z</td>
| + | |
| - | <td>Stronger Signaling</td>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <td>Carmen</td>
| + | |
| - | <td>antiMESOCAR-FcRg-DAP10</td>
| + | |
| - | <td>Stronger Signaling</td>
| + | |
| - | </tr>
| + | |
| - | | + | |
| - | <tr class="alt">
| + | |
| - | <td>Carmen</td>
| + | |
| - | <td>antiMESOCAR-ICOS-DAP10</td>
| + | |
| - | <td>Stronger Signaling</td>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <td>Carmen</td>
| + | |
| - | <td>antiCD19CAR-FcRg-DAP10</td>
| + | |
| - | <td>Stronger Signaling</td>
| + | |
| - | </tr>
| + | |
| - | | + | |
| - | <tr class="alt">
| + | |
| - | <td>Carmen</td>
| + | |
| - | <td>antiCD19CAR-ICOS-DAP10</td>
| + | |
| - | <td>Stronger Signaling</td>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <td>Carmen</td>
| + | |
| - | <td>antiCD19CAR-LFA1-DAP10</td>
| + | |
| - | <td>Stronger Signaling</td>
| + | |
| - | </tr>
| + | |
| - | | + | |
| - | <tr class="alt">
| + | |
| - | <td>Crystal</td>
| + | |
| - | <td>antiMESOCAR-CD3z-CD3z</td>
| + | |
| - | <td>Stronger Signaling</td>
| + | |
| - | </tr>
| + | |
| - | <tr>
| + | |
| - | <td>Lianna</td>
| + | |
| - | <td>antiMESOCAR-mDAP10Y85F-STOP</td>
| + | |
| - | <td>Logic Gate Negative Control</td>
| + | |
| | </tr> | | </tr> |
| | | | |
| - | <tr class="alt">
| |
| - | <td>Connor</td>
| |
| - | <td>antiCD19CAR-KIR3DL1-STOP</td>
| |
| - | <td>Inhibition</td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Connor</td>
| |
| - | <td>antiMESOCAR-KIR3DL1-STOP</td>
| |
| - | <td>Inhibition</td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Crystal</td>
| |
| - | <td>antiMESOCAR-DAP10-STOP</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Lianna</td>
| |
| - | <td>antiCD19CAR-OX40-DAP10</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Lianna</td>
| |
| - | <td>antiCD19CAR-OX40-CD3z</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Carmen</td>
| |
| - | <td>antiCD19CAR-SLAMF1-CD3z</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Carmen</td>
| |
| - | <td>antiCD19CAR-SLAMF1-DAP10</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Carmen</td>
| |
| - | <td>antiCD19CAR-SLAMF5-DAP10</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>John</td>
| |
| - | <td>antiMESOCAR-SLAMF1-CD3z</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>John</td>
| |
| - | <td>antiMESOCAR-SLAMF5-DAP10</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Lianna</td>
| |
| - | <td>antiCD19CAR-FcRg-STOP</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Lianna</td>
| |
| - | <td>antiCD19CAR-ICOS-STOP</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Lianna</td>
| |
| - | <td>antiCD19CAR-CD28-STOP</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Lianna</td>
| |
| - | <td>antiMESOCAR-FcRg-STOP</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Lianna</td>
| |
| - | <td>antiMESOCAR-ICOS-STOP</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Lianna</td>
| |
| - | <td>antiMESOCAR-CD28-STOP</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Lianna</td>
| |
| - | <td>antiCD19CAR-LFA1-STOP</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Lianna</td>
| |
| - | <td>antiMESOCAR-LFA1-STOP</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Crystal</td>
| |
| - | <td>antiCD19CAR-LFA1-CD3z</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Crystal</td>
| |
| - | <td>antiMESOCAR-OX40-STOP</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Crystal</td>
| |
| - | <td>antiMESOCAR-SLAMF3-CD3z</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Crystal</td>
| |
| - | <td>antiMESOCAR- CD3g-CD3z</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Crystal</td>
| |
| - | <td>antiMESOCAR-Ly49-STOP</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Crystal</td>
| |
| - | <td>antiMESOCAR-NKG2A-STOP</td>
| |
| - | <td>Negative Feedback</td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Crystal</td>
| |
| - | <td>antiCD19CAR-OX40-STOP</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Crystal</td>
| |
| - | <td>antiCD19CAR-SLAMF3-CD3z</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Crystal</td>
| |
| - | <td> antiCD19CAR-CD3g-CD3z</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Crystal</td>
| |
| - | <td>antiCD19CAR-FcRg-CD3z</td>
| |
| - | <td>Stronger Signaling</td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Min</td>
| |
| - | <td>GZMB-eGFP-CDMPR</td>
| |
| - | <td>Localization to Cytoxic Granules </td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Min</td>
| |
| - | <td>GZMB-eGFP-GILT</td>
| |
| - | <td>Localization to Cytoxic Granules </td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Min</td>
| |
| - | <td>GZMB-eGFP-LAMP</td>
| |
| - | <td>Localization to Cytoxic Granules </td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Min</td>
| |
| - | <td>GZMB-eGFP-LIMP</td>
| |
| - | <td>Localization to Cytoxic Granules </td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Min</td>
| |
| - | <td>GZMB-eGFP-Ymotif</td>
| |
| - | <td>Localization to Cytoxic Granules </td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Min</td>
| |
| - | <td>GZMB-eGFP-STP</td>
| |
| - | <td>Localization to Cytoxic Granules </td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Min</td>
| |
| - | <td>GZMM-eGFP-CDMPR</td>
| |
| - | <td>Localization to Cytoxic Granules </td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Min</td>
| |
| - | <td>GZMM-eGFP-GILT</td>
| |
| - | <td>Localization to Cytoxic Granules </td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Min</td>
| |
| - | <td>GZMM-eGFP-LAMP</td>
| |
| - | <td>Localization to Cytoxic Granules </td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Min</td>
| |
| - | <td>GZMM-eGFP-LIMP</td>
| |
| - | <td>Localization to Cytoxic Granules </td>
| |
| - | </tr>
| |
| - |
| |
| - | <tr class="alt">
| |
| - | <td>Min</td>
| |
| - | <td>GZMM-eGFP-Ymotif</td>
| |
| - | <td>Localization to Cytoxic Granules </td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>Min</td>
| |
| - | <td>GZMM-eGFP-STP</td>
| |
| - | <td>Localization to Cytoxic Granules </td>
| |
| - | </tr>
| |
| | </table> | | </table> |
| | | | |
| | + | --> |
| | | | |
| | <br> | | <br> |
"
